• Ocular allergy/inflammation

Bromsite Generic Name & Formulations

General Description

Bromfenac 0.075%; oph soln; contains benzalkonium chloride.

Pharmacological Class


How Supplied


Generic Availability


Bromsite Indications


Post-operative inflammation and prevention of ocular pain following cataract surgery.

Bromsite Dosage and Administration


≥18yrs: 1 drop in affected eye twice daily starting 1 day before surgery, continued on day of surgery, and for 14 days post-op. May be given with other topical ophthalmics (eg, alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, mydriatics); administer at least 5 mins apart.


<18yrs: not established.

Bromsite Contraindications

Not Applicable

Bromsite Boxed Warnings

Not Applicable

Bromsite Warnings/Precautions


Bleeding tendencies. May slow or delay wound healing. Potential for cross-sensitivity to acetylsalicylic acid, phenylacetic acid derivatives, other NSAIDs. Complicated/repeat ocular surgeries. Corneal defects/denervation. Ocular surface diseases. Rheumatoid arthritis. Diabetes. Monitor cornea; discontinue if corneal epithelial breakdown occurs. Risk of corneal adverse events may be increased if used >24hrs before surgery, or beyond 14-days post-op. Contact lenses (remove during therapy). Pregnancy: avoid during late pregnancy. Nursing mothers.

Bromsite Pharmacokinetics

See Literature

Bromsite Interactions


Concomitant topical NSAIDs and corticosteroids may potentiate healing problems. Caution with concomitant drugs that prolong bleeding time.

Bromsite Adverse Reactions

Adverse Reactions

Anterior chamber inflammation, headache, vitreous floaters, iritis, eye pain, ocular hypertension; keratitis, corneal reactions (eg, epithelial breakdown, thinning, erosion, ulceration/perforation).

Bromsite Clinical Trials

See Literature

Bromsite Note

Not Applicable

Bromsite Patient Counseling

See Literature